Research Article

Rab22a Promotes Epithelial-Mesenchymal Transition in Papillary Thyroid Carcinoma by Activating PI3K/AKT/mTOR Signaling Pathway

Figure 6

The PI3K inhibitors reduced Rab22a promoting the proliferation of thyroid cancer cells. The TPC1 and K1 cell proliferation were decreased by PI3K inhibitor treatment, as shown by CCK8 and colony formation assays (a and b). Data are shown as of the three independent experiments: , , and .
(a)
(b)